Xla Wt + lbx1 MO has 8 phenotype(s)
Images Sources Experiment + Assay Phenotypes Human Diseases
Fig.7, A B

Martin BL and Harland RM (2006) 		Xla Wt + lbx1 MO

NF22 (in situ hybridization)
Expression Phenotype
decreased amount myod1.S expression in paraxial mesoderm
Fig.7, F G

Martin BL and Harland RM (2006) 		Xla Wt + lbx1 MO

NF22 (in situ hybridization)
Expression Phenotype
increased amount pax3.S expression in paraxial mesoderm
Fig.7, L

Martin BL and Harland RM (2006) 		Xla Wt + lbx1 MO

NF24 (in situ hybridization)
Expression Phenotype
decreased amount lhx1 expression in myoblast
Fig.5B

Martin BL and Harland RM (2006) 		Xla Wt + lbx1 MO

NF28 (immunohistochemistry)
Anatomical Phenotype
abnormally wholly dorsalized epaxial muscle
abnormally wholly dorsalized trunk somite
absent hypaxial muscle
decreased size of the trunk somite
Fig.6 E, F

Martin BL and Harland RM (2006) 		Xla Wt + lbx1 MO

NF28-33/34 (immunohistochemistry)
Anatomical Phenotype
decreased cell population proliferation in myotome
decreased cell population proliferation in somite
decreased size of the myotome
Fig.7, D E

Martin BL and Harland RM (2006) 		Xla Wt + lbx1 MO

NF33/34 (in situ hybridization)
Expression Phenotype
decreased amount myod1.S expression in paraxial mesoderm
Fig.7, I J

Martin BL and Harland RM (2006) 		Xla Wt + lbx1 MO

NF33/34 (in situ hybridization)
Anatomical Phenotype
decreased size of the head
Expression Phenotype
increased amount pax3.S expression in paraxial mesoderm
Fig.7, M

Martin BL and Harland RM (2006) 		Xla Wt + lbx1 MO

NF33/34 (in situ hybridization)
Expression Phenotype
decreased amount lhx1 expression in trunk somite